Clinical Trial Update: Oral Aromatase Inhibitors Modify the Gut Microbiome

View source ↗

Summary

A clinical trial is recruiting to study whether oral aromatase inhibitors affect the gut microbiome in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Breast Cancer | Status: RECRUITING